openPR Logo
Press release

Covid-19 impact on - Thyroid Cancer Drug Market 2020 Industry Research, Share, Trend, Industry Size, Price, Future Analysis, Regional Outlook to 2026 Research Report | DBMR Updates

Thyroid Cancer Drug Market

Thyroid Cancer Drug Market

Global Thyroid Cancer Drug Market report has an assessment of the factors influencing the supply and demand of the related products and services, and challenges reckoned by market players. It has projected strong upcoming growth of the market. The Thyroid Cancer Drug Market research report combines secondary research which includes reference to different statistical databases, related patent and regulatory bibliography and a number of internal and external proprietary information. The report starts with a market outlook together with the data integration and capabilities study with the appropriate findings. With the help of key information and market insights from technical and marketing experts, this market report offers an objective estimation of the Thyroid Cancer Drug market.

Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-thyroid-cancer-drug-market

Global thyroid cancer drug market is rise gradually to an estimated value of USD 2404.8 million by 2026 registering a CAGR of 24.3% in the forecast period of 2019-2026. Increasing prevalence of thyroid cancer and accelerating demand of clinical treatment and novel therapies indicates the significant growth of market.

Few of the major competitors currently working in the thyroid cancer drug market are Mylan N.V., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Jerome Stevens Pharmaceuticals, Inc, Baxter, Abbott, Celgene Corporation, AstraZeneca, GlaxoSmithKline plc, Eisai Co., Ltd, Takeda Pharmaceutical Company Ltd, Biovista, Cytori Therapeutics Inc, Bayer AG, Novartis AG, Bio-Path Holdings, Inc, Vascular Biogenics, and few among others.

Market Analysis:
Besides target market information, DBMR also provides information about your competitor, your customers, products etc. A few techniques we use are:
Customer analysis
Competitor analysis
Risk analysis
Product research
Advertising research
E-mail survey and many more...

Read Complete Details with TOC Here https://www.databridgemarketresearch.com/toc/?dbmr=global-thyroid-cancer-drug-market

Market Definition: Global Thyroid Cancer Drug Market

Thyroid cancer is also known as thyroid nodules is a cancer occur in thyroid gland and can spread to other parts of the body and about 90% of all thyroid cancers are benign.

According to the statistics published in American Cancer Society 2019, it is estimated that 52,070 patients to be diagnosed with thyroid cancer in the United States in this current year. It is more prevalent in women and near 2% of cases occurs in children. Growing population of thyroid cancer and adopting unhealthy life style are the key factors for market growth.

Segmentation: Global Thyroid Cancer Drug Market

Thyroid Cancer Drug Market : By Type

Papillary thyroid cancer
Follicular thyroid cancer
Hurthle cell cancer
Medullary thyroid cancer (MTC)
Anaplastic thyroid cancer

Thyroid Cancer Drug Market : By Drug Type

Thyroid desiccated
Sorafenib
Thyrotropin alfa
Vandetanib
Doxorubicin
Cabozantinib
Lenvatinib
Sodium iodide I-131
Dabrafenib
Trametinib
Others

Thyroid Cancer Drug Market : By Treatment

Medication
Chemotherapy
Radioactive iodine (radioiodine) therapy
Hormone therapy
Surgery

Thyroid Cancer Drug Market : By Route of administration

Oral
Injectable
Others

Thyroid Cancer Drug Market : By End users

Hospitals
Homecare
Specialty Clinics
Others

Thyroid Cancer Drug Market : By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Key Developments in the Market:

In May 2018, Novartis AG received FDA approval for Tafinlar in combination with Mekinist (trametinib) for the treatment of anaplastic thyroid cancer comprising of abnormal gene known as BRAF V600E
In March 2018, Eisai Co., Ltd and Merck & Co., Inc entered into research collaboration for exclusive worldwide co-development and co- commercialization of Lenvima in combination with pembrolizumab for 11 potential indications in six types of cancer (endometrial cancer, non-small cell lung cancer, hepatocellular carcinoma, head and neck cancer, bladder cancer and melanoma). Lenvima has been approved from the FDA for the treatment of differentiated thyroid cancer

Thyroid Cancer Drug Market Drivers :

Increase in prevalence rate of neuroendocrine tumor worldwide
Accelerating demand of treatment and novel therapies
Rising awareness about treatment and technological advancement is driving the growth of market
Increases cases of obesity and adopting unhealthy life style

Thyroid Cancer Drug Market Restraints :

Effective treatment is either unavailable or unaffordable
Patent expiry of the patented drugs and introduction of generic version of branded drugs is expected to restrain the growth if the market
Inadequate awareness about thyroid cancer treatment in some developing countries

Reasons to Purchase this Report :

Current and future of global thyroid cancer drug market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

This all-inclusive Thyroid Cancer Drug Market report sheds light on each region, market size in terms of USD Mn for every individual segment and their sub-segment for the period from 2020 to 2026, considering the macro and micro situation factors. The document gives a brief introduction to the research report outlook, TOC, list of tables and figures & an outlook to key players of the market comprising key regions. An extensive summary of the Thyroid Cancer Drug Market has prominent market that includes several major market leaders in the report. The report necessitates an in-depth analysis pertaining to the product manufactured by the vendors combining with the product application range.

Want Full Report? Enquire Here https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-thyroid-cancer-drug-market

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Covid-19 impact on - Thyroid Cancer Drug Market 2020 Industry Research, Share, Trend, Industry Size, Price, Future Analysis, Regional Outlook to 2026 Research Report | DBMR Updates here

News-ID: 2062055 • Views: 203

More Releases from Data Bridge Market Research Pvt. Ltd.

Chronic Fatigue Syndrome Market 2020 | Industry Size, Share, Growth Factors, Top …
This Chronic Fatigue Syndrome Market report includes a wide-ranging evaluation of the market’s growth prospects and restrictions. The Chronic Fatigue Syndrome Market report provides estimations about the growth rate and the market value in ABC industry based on market dynamics and growth inducing factors. Global Chronic Fatigue Syndrome Market report studies the industry abilities for each geographical region based on the customer purchasing patterns, macroeconomic parameters, development rate, and market
Psychedelic Drugs Market 2020 Insights, Industry Growth Factors, Applications, D …
This Psychedelic Drugs Market report includes a wide-ranging evaluation of the market’s growth prospects and restrictions. The Psychedelic Drugs Market report provides estimations about the growth rate and the market value in ABC industry based on market dynamics and growth inducing factors. Global Psychedelic Drugs Market report studies the industry abilities for each geographical region based on the customer purchasing patterns, macroeconomic parameters, development rate, and market demand and supply
Adalimumab Market 2020 Sees a Faster Rebound in the Era of COVID-19 | Industry S …
This Adalimumab Market report includes a wide-ranging evaluation of the market’s growth prospects and restrictions. The Adalimumab Market report provides estimations about the growth rate and the market value in ABC industry based on market dynamics and growth inducing factors. Global Adalimumab Market report studies the industry abilities for each geographical region based on the customer purchasing patterns, macroeconomic parameters, development rate, and market demand and supply states. In addition,
Medical Display Market 2020 Sees a Faster Rebound in the Era of COVID-19 | Indus …
This Medical Display Market report includes a wide-ranging evaluation of the market’s growth prospects and restrictions. The Medical Display Market report provides estimations about the growth rate and the market value in ABC industry based on market dynamics and growth inducing factors. Global Medical Display Market report studies the industry abilities for each geographical region based on the customer purchasing patterns, macroeconomic parameters, development rate, and market demand and supply

All 5 Releases


More Releases for Thyroid

Thyroid Gland Disorders Treatment Market Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of
Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of
Global Medullary Thyroid Cancer Drugs Market Research Report 2016
This report studies Medullary Thyroid Cancer Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Sinofi Genzyme Exelixis Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Medullary Thyroid Cancer Drugs in these regions, from 2011
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
Thyroid gland is made of thyroid cells that absorb iodine from food and convert it into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism. Thyroid gland disorders are defined as an abnormal release of thyroid hormones which may demand proper therapeutic agents to correct the disorder condition. This report studies the market in a view
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
The number of patients suffering from thyroid gland disorders across the globe is increasing at a rapid rate. This direct increase in demand is expected to be a primary driver for the development of thyroid gland disorder treatments. The number of patients with thyroid gland disorder is increasing due to a growing population of the elderly, who are prone to thyroid disorders and similar illnesses. Additionally, a person suffering from